Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cyclohexylamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105712901B reveals a cost-effective enzymatic route for Hepatitis C intermediates. Discover scalable manufacturing and supply chain advantages.
Patent CN119530189A reveals green enzymatic route for cyclohexylamine. Offers high selectivity and reduced environmental impact for pharmaceutical intermediate supply chains.
Patent CN1140496C reveals advanced ruthenium catalyst technology for aromatic amine hydrogenation. Delivers high purity cycloaliphatic amines with significant supply chain and cost advantages for global manufacturers.
Patent CN102993024B reveals a safer sulfonation-methylation route for N,N'-dimethyl cyclohexanediamine, offering high purity >98% and significant cost reduction in fine chemical manufacturing.
Patent CN114890913B reveals a high-yield synthesis of dicyanoethyl cyclohexylamine using recyclable acidic ionic liquids, ensuring ultra-low acid content for downstream hydrogenation.
Patent CN105439870A details solvent-free DCU recycling yielding high-purity cyclohexylamine. This process offers substantial cost reduction and supply chain reliability for global buyers.
Patent CN117756644A reveals a novel method converting caprolactam by-products into high-purity N-hexylcyclohexylamine, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN106278904B enables efficient cyclohexylamine production via benzene one-pot method. Reduces waste acid and offers cost reduction in fine chemical intermediates manufacturing.
Novel crystalline cephamycin intermediate via salt formation. Enhances stability and purity for cefminox sodium production. Reliable supply chain solution.